{"id":3603136,"date":"2022-10-10T08:00:00","date_gmt":"2022-10-10T12:00:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/"},"modified":"2025-03-07T23:39:27","modified_gmt":"2025-03-08T04:39:27","slug":"merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/","title":{"rendered":"Merck Recognized on Fortune\u2019s 2022 Change the World List for Expanding Access to HPV Vaccines"},"content":{"rendered":"<div class=\"q4default\">\n<p>    RAHWAY, N.J.&#8211;(BUSINESS WIRE)&#8211;<br \/>\nMerck (NYSE: MRK), known as MSD outside the United States and Canada, has been named to Fortune\u2019s 2022 Change the World list. The annual list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Merck was selected for its work expanding global access to the company\u2019s human papillomavirus (HPV) vaccines.\n<\/p>\n<p>\n\u201cIt\u2019s an honor for Merck to be included on Fortune\u2019s 2022 Change the World List, and recognized for making our HPV vaccines available to communities around the world,\u201d said Robert M. Davis, chief executive officer and president, Merck. \u201cThis is the third time over the last five years that our company has been on this list and we are very proud of being acknowledged for the positive impact we continue to make on global health. Our commitment and efforts in this space reflect Merck\u2019s distinguished legacy of operating responsibly and creating value for society. Importantly, we know that even more needs to be done to advance health equity, and our team is inspired and passionate about finding new ways to bring our medicines and vaccines to people and communities everywhere.\u201d\n<\/p>\n<p>\nMerck\u2019s access strategy for our HPV vaccines is fully aligned to the company\u2019s <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvip2-msd.com\/merckcom-migrated%2Fcompany-overview%2Fesg%2F&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=Environmental%2C+Social%2C+Governance+%28ESG%29&amp;index=1&amp;md5=7da6eccb61cc6173a3c981d2564b6dbe\">Environmental, Social, Governance (ESG)<\/a> strategy, and specifically Merck\u2019s commitment to expand access for people and communities around the globe. Among the specific actions Merck has taken with our HPV vaccines are:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nCollaborating with UNICEF on a <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvip2-msd.com\/merckcom-migrated%2Fnews%2Fexpansion-of-elkton-virginia-manufacturing-facility-to-further-increase-mercks-hpv-vaccine-supply-and-support-broader-and-equitable-access%2F&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=long-term+agreement&amp;index=2&amp;md5=52bdf6d46d196d218c20c24556fa09fa\">long-term agreement<\/a> to provide 91.5 million doses for use in Gavi-supported countries from 2021 to 2025;\n<\/li>\n<li>\nMaking more than $2 billion in capital investments over the last five years to help increase supply of our HPV vaccines to extend access globally;\n<\/li>\n<li>\nObtaining prequalification in May 2022 from WHO for our HPV vaccines to be used outside the cold chain for up to four days, helping to enhance accessibility for hard-to-reach populations.\n<\/li>\n<\/ul>\n<p>\nThis recognition marks the third time in five years that Merck has been included on Fortune\u2019s Change the World list. Merck was previously recognized in <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.3blmedia.com%2Fnews%2Fmerck-ranked-no-2-fortune-magazines-2018-change-world-list&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=2018&amp;index=3&amp;md5=33c71b2418cf66f2fa971c790e5604a6\">2018<\/a> for its leadership in the fight against Ebola, and in <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvip2-msd.com\/merckcom-migrated%2Fstories%2Fadvancing-health-equity-through-impact-investing%2F&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=2020&amp;index=4&amp;md5=e96ce5e1d43d7ea88278669b484c4d79\">2020<\/a> for its impact investing program. Fortune selects companies for this honor based on a set of criteria including the measurable social impact of their work to meet unmet social needs, the links between this work and successful business results, the degree of innovation demonstrated and integration of their socially beneficial work into their larger corporate identity.\n<\/p>\n<p>\n  <b>About Merck<\/b>\n<\/p>\n<p>\nAt Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world \u2013 and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fvip2-msd.com\/merckcom-migrated%2F&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=vip2-msd.com\/merckcom-migrated&amp;index=5&amp;md5=af269ebfb1ef0b24fff204e337090e8d\">vip2-msd.com\/merckcom-migrated<\/a> and connect with us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FMerck&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=Twitter&amp;index=6&amp;md5=47092c695cd0b4b39614722da9501d85\">Twitter<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FMerckInvents%2F&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=Facebook&amp;index=7&amp;md5=debdce2199dcd4ff3d83094babf2cfd3\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fmerck%2F&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=Instagram&amp;index=8&amp;md5=cbbb4cb5dfdf5053fc6627f3419be939\">Instagram<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.youtube.com%2FMerck&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=YouTube&amp;index=9&amp;md5=db1318bbc75e82d13f0eea219d5008bd\">YouTube<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fmerck&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=10&amp;md5=9c089cf07868cb4bac8d83fe5557abfa\">LinkedIn<\/a>.\n<\/p>\n<p>\n  <b>Forward-Looking Statement of Merck &amp; Co., Inc., Rahway, N.J., USA<\/b>\n<\/p>\n<p>\nThis news release of Merck &amp; Co., Inc., Rahway, N.J., USA (the \u201ccompany\u201d) includes \u201cforward-looking statements\u201d within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company\u2019s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.\n<\/p>\n<p>\nRisks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company\u2019s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company\u2019s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and\/or regulatory actions.\n<\/p>\n<p>\nThe company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company\u2019s Annual Report on Form 10-K for the year ended December 31, 2021 and the company\u2019s other filings with the Securities and Exchange Commission (SEC) available at the SEC\u2019s Internet site (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=52940243&amp;newsitemid=20221007005569&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=11&amp;md5=7396c80378e8d1ad5887c7228ca12762\">www.sec.gov<\/a>).\n<\/p>\n<p>\n  <img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221007005569r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"><br \/>\n  <span class=\"bwct31415\"><\/span>\n<\/p>\n<p id=\"mmgallerylink\">\n  <span id=\"mmgallerylink-phrase\">View source version on <a href=\"http:\/\/businesswire.com\">businesswire.com<\/a>: <\/span><br \/>\n  <span id=\"mmgallerylink-link\"><br \/>\n    <a href=\"https:\/\/www.businesswire.com\/news\/home\/20221007005569\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20221007005569\/en\/<\/a><br \/>\n  <\/span>\n<\/p>\n<p>\nMedia:<br \/>\n<br \/>Patrick Ryan<br \/>\n<br \/>(973) 275-7075<\/p>\n<p>Investors:<br \/>\n<br \/>Peter Dannenbaum<br \/>\n<br \/>(908) 740-1037\n<\/p>\n<p>Source: Merck &amp; Co., Inc.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been named to Fortune\u2019s 2022 Change the World list. The annual list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Merck was selected for its work expanding global access to the company\u2019s human papillomavirus (HPV) vaccines. \u201cIt\u2019s an honor for Merck to be included on Fortune\u2019s 2022 Change the World List, and recognized for making our HPV vaccines available to communities around the world,\u201d said Robert M. Davis, chief executive officer and president, Merck. \u201cThis is the third time over the last five years that our company has been on this list and we are very proud of being acknowledged for the positive impact we continue to make on global health. Our commitment and efforts in this space reflect Merck\u2019s distinguished legacy of operating responsibly and creating value for society. Importantly, we know that even more needs to be done to<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[53,289],"class_list":["post-3603136","news_item","type-news_item","status-publish","hentry","tag-corporate-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck Recognized on Fortune\u2019s 2022 Change the World List for Expanding Access to HPV Vaccines - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Recognized on Fortune\u2019s 2022 Change the World List for Expanding Access to HPV Vaccines - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been named to Fortune\u2019s 2022 Change the World list. The annual list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Merck was selected for its work expanding global access to the company\u2019s human papillomavirus (HPV) vaccines. \u201cIt\u2019s an honor for Merck to be included on Fortune\u2019s 2022 Change the World List, and recognized for making our HPV vaccines available to communities around the world,\u201d said Robert M. Davis, chief executive officer and president, Merck. \u201cThis is the third time over the last five years that our company has been on this list and we are very proud of being acknowledged for the positive impact we continue to make on global health. Our commitment and efforts in this space reflect Merck\u2019s distinguished legacy of operating responsibly and creating value for society. Importantly, we know that even more needs to be done to\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-08T04:39:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221007005569r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\\\/\",\"name\":\"Merck Recognized on Fortune\u2019s 2022 Change the World List for Expanding Access to HPV Vaccines - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20221007005569r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2022-10-10T12:00:00+00:00\",\"dateModified\":\"2025-03-08T04:39:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20221007005569r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20221007005569r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Recognized on Fortune\u2019s 2022 Change the World List for Expanding Access to HPV Vaccines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck Recognized on Fortune\u2019s 2022 Change the World List for Expanding Access to HPV Vaccines - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/","og_locale":"en_US","og_type":"article","og_title":"Merck Recognized on Fortune\u2019s 2022 Change the World List for Expanding Access to HPV Vaccines - Merck.com","og_description":"Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been named to Fortune\u2019s 2022 Change the World list. The annual list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Merck was selected for its work expanding global access to the company\u2019s human papillomavirus (HPV) vaccines. \u201cIt\u2019s an honor for Merck to be included on Fortune\u2019s 2022 Change the World List, and recognized for making our HPV vaccines available to communities around the world,\u201d said Robert M. Davis, chief executive officer and president, Merck. \u201cThis is the third time over the last five years that our company has been on this list and we are very proud of being acknowledged for the positive impact we continue to make on global health. Our commitment and efforts in this space reflect Merck\u2019s distinguished legacy of operating responsibly and creating value for society. Importantly, we know that even more needs to be done to","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/","og_site_name":"Merck.com","article_modified_time":"2025-03-08T04:39:27+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221007005569r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/","name":"Merck Recognized on Fortune\u2019s 2022 Change the World List for Expanding Access to HPV Vaccines - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/#primaryimage"},"image":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221007005569r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en","datePublished":"2022-10-10T12:00:00+00:00","dateModified":"2025-03-08T04:39:27+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221007005569r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20221007005569r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognized-on-fortunes-2022-change-the-world-list-for-expanding-access-to-hpv-vaccines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck Recognized on Fortune\u2019s 2022 Change the World List for Expanding Access to HPV Vaccines"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"89f6dad0-6f0a-498f-b695-6fe665ae2f32","news_item_aria_label":"","media_files":[{"path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_multimedia\/Merck_Logo_Horizontal_Teal-Grey_RGB.jpg","size":"211320","File Upload":""}],"document_path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_news\/Merck-Recognized-on-Fortunes-2022-Change-the-World-List-for-Expanding-Access-to-HPV-Vaccines-2022.pdf","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/3603136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":0,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/3603136\/revisions"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=3603136"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=3603136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}